Search

everythinglearnresearchcommunity

for

Search:↓

New effective scar treatments are urgently needed due to the current options' limited success.

Oestrogens are key for bone growth during puberty in both boys and girls.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Current treatments for alopecia show no significant long-term benefits.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Pegvaliase is recommended for treating adults with phenylketonuria.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Vitiligo affects overall health and self-esteem, needing more research and awareness.